Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $2.33 Million - $2.86 Million
20,400 Added 1.13%
1,823,400 $253 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $12.5 Million - $20.5 Million
165,300 Added 10.09%
1,803,000 $224 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $141 Million - $226 Million
1,637,700 New
1,637,700 $153 Million
Q2 2023

Aug 11, 2023

SELL
$112.47 - $130.98 $19 Million - $22.1 Million
-168,500 Reduced 9.08%
1,686,500 $217 Million
Q1 2023

May 12, 2023

BUY
$104.0 - $122.92 $53.7 Million - $63.5 Million
516,800 Added 38.62%
1,855,000 $216 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $114 Million - $164 Million
1,338,200 New
1,338,200 $152 Million
Q2 2022

Aug 15, 2022

SELL
$67.99 - $132.89 $16 Million - $31.2 Million
-234,800 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $9.07 Million - $12.6 Million
-96,400 Reduced 29.11%
234,800 $119 Million
Q4 2021

Feb 15, 2022

BUY
$129.87 - $162.82 $9.95 Million - $12.5 Million
76,625 Added 30.1%
331,200 $179 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $27.2 Million - $36.5 Million
254,575 New
254,575 $138 Million
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $33.5 Million - $44.8 Million
-429,000 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $1.84 Million - $2.18 Million
-19,300 Reduced 4.31%
429,000 $172 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $7.14 Million - $12 Million
113,900 Added 34.06%
448,300 $177 Million
Q1 2020

May 14, 2020

SELL
$47.79 - $75.63 $2.92 Million - $4.63 Million
-61,200 Reduced 15.47%
334,400 $91.1 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $1.72 Million - $2.69 Million
46,900 Added 13.45%
395,600 $84.3 Million
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $5 Million - $6.17 Million
140,800 Added 67.72%
348,700 $50.6 Million
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $2.05 Million - $2.87 Million
-73,700 Reduced 26.17%
207,900 $29.5 Million
Q1 2019

May 15, 2019

SELL
$28.07 - $38.18 $4.7 Million - $6.4 Million
-167,500 Reduced 37.3%
281,600 $32.7 Million
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $11.7 Million - $16.2 Million
432,600 Added 2621.82%
449,100 $52.4 Million
Q3 2018

Nov 14, 2018

BUY
$23.35 - $36.72 $385,275 - $605,880
16,500 New
16,500 $2.36 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.